3-Pronged Approach Needed To Increase Access To Antibiotics, AMR Industry Alliance Board Member Writes In Opinion Piece
Devex: Opinion: How to oppose the menace of antimicrobial resistance
Serufusa Sekidde, board member of the AMR Industry Alliance
“…5.7 million people, including 1 million children, are dying annually from antibiotic-treatable conditions because they cannot access the necessary antibiotics in time. … To increase access to antibiotics …, we need a three-pronged approach: … First, to increase availability, we need to ensure that any novel antibiotics we research and develop are registered in more countries. … Secondly, we need to ensure that all antibiotics available on the market are of high quality and appropriately used. … Lastly, no single entity can tackle the lack of access to antibiotics on its own, so we must focus on building and strengthening new and existing partnerships. … That’s why it is significant that a diverse coalition of biotechnology, diagnostics, generics, and large research-based biopharmaceutical companies and associations — the AMR Industry Alliance — has come together to add their expertise and resources to the fight against AMR…” (1/20).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.